Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, October 18, 2018 · 465,471,009 Articles · 3+ Million Readers

Post-Traumatic Stress Disorder (PTSD) -New Report by Companies Involved in Therapeutics Development, H1 2018

Post-Traumatic Stress Disorder

PUNE, MAHARASHTRA, INDIA, February 20, 2018 /EINPresswire.com/ --

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Post-Traumatic Stress Disorder - Pipeline Review, H1 2018”

Post-Traumatic Stress Disorder

Overview

Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by a terrifying event either experiencing it or witnessing it. Symptoms include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event. Treatment includes antidepressants, anti-anxiety and cognitive therapy.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811441-post-traumatic-stress-disorder-ptsd-pipeline-review-h1-2018

Top Companies mentioned

Addex Therapeutics Ltd

Bionomics Ltd

Catalyst Pharmaceuticals Inc

Eli Lilly and Co

Synchroneuron Inc

Tonix Pharmaceuticals Holding Corp

Post-Traumatic Stress Disorder Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Post-Traumatic Stress Disorder  - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Post-Traumatic Stress Disorder , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 5, 16 and 3 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 6 and 1 molecules, respectively.

Post-Traumatic Stress Disorder pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Post-Traumatic Stress Disorder - Competitive Analysis

Key players are making innovative developments in Post-Traumatic Stress Disorder industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Traumatic Stress Disorder.

The pipeline guide reviews pipeline therapeutics for Post-Traumatic Stress Disorder by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Post-Traumatic Stress Disorder therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Post-Traumatic Stress Disorder therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Post-Traumatic Stress Disorder.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811441-post-traumatic-stress-disorder-ptsd-pipeline-review-h1-2018

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire